铅归因心血管疾病负担:2023年全球疾病负担研究
该研究基于美国NHANES 1988-2013年9个周期42 028名成人数据(随访至2015年12月,捕获1748例心血管死亡),结合系统综述与贝叶斯meta回归构建骨铅暴露-反应曲线,并估算1990至2023年全球铅归因心血管疾病负担。
要点
- 骨铅水平与心血管死亡风险呈暴露-反应关系,水平越高风险越大。
- 2023年全球铅归因死亡占全部死亡的5.8%,铅为全球第八大死亡风险因素。
- 需加强监测、监管与修复以降低铅归因心血管疾病负担。
核心结论
- 累积铅暴露仍是全球心血管死亡的重要且可预防的贡献因素。
- 亟需加强监测、监管与修复以减少铅归因疾病负担。
研究设计与样本
- 分析美国NHANES 1988至2013年9个周期42 028名成人,随访至2015年12月捕获1748例心血管死亡。
- 结合系统综述与贝叶斯meta回归(Burden of Proof框架)构建骨铅暴露-反应曲线。
- 将风险曲线应用于铅暴露与心血管疾病估计,估算人群归因分数与铅归因负担。
主要发现
- 参与者年龄18至90岁(中位46岁,IQR 32-63),女性占51.5%,估计骨铅范围0.17至301 μg/g(中位13.3 μg/g)。
- 相对前工业水平0.027 μg/g,骨铅5、10、25、50、100 μg/g对应心血管死亡风险分别增加7.5%(95% UI 1.7%-14.1%)、15.8%(12.7%-19.1%)、41.3%(34.2%-49.2%)、71.3%(55.4%-90.0%)、87.9%(61.0%-121.2%)。
- 铅归因死亡占全部死亡的5.8%(95% UI 4.3%-7.2%),归因DALYs占2.6%(1.8%-3.2%)。
- 铅为全球第八大死亡风险因素和第二大环境风险因素。
临床怎么用
- 可将骨铅暴露水平纳入心血管风险评估,关注累积铅暴露人群。
- 强化铅暴露监测、监管与环境污染修复,以降低心血管疾病负担。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Despite declines, lead exposure remains a major risk factor for cardiovascular disease (CVD) mortality. Quantifying the direct effects of cumulative bone lead exposure on CVD is essential to guide prevention and policy. OBJECTIVES: To estimate the association between bone lead levels and CVD, derive an exposure-response curve, and estimate global, regional, and national lead-attributable disease burden for 1990 to 2023. DESIGN, SETTING, AND PARTICIPANTS: Analysis of 42 028 adults from 9 cycles of the US National Health and Nutrition Examination Survey (NHANES) spanning 1988 through 2013, with follow-up through December 2015 capturing 1748 CVD deaths, was combined with a systematic review and meta-regression. Bone lead was estimated from blood lead, age, and cohort-specific exposure histories. Cox proportional hazards models adjusted for blood pressure and confounders estimated hazard ratios for CVD mortality. A bayesian meta-regression using the Burden of Proof framework pooled NHANES results with published data to estimate the risk curve, which was then applied to lead exposure and CVD estimates to estimate population-attributable fractions and lead-attributable CVD burden. EXPOSURE: Estimated bone lead levels. MAIN OUTCOMES AND MEASURES: Lead-attributable CVD mortality, years lived with disability, years of life lost, and disability-adjusted life-years (DALYs) by age, sex, year, and location. RESULTS: NHANES participants were aged 18 to 90 years (median, 46 [IQR, 32-63] years) and 51.5% of participants were female, with estimated bone lead levels ranging from 0.17 μg/g to 301 μg/g (median, 13.3 μg/g). Higher bone lead levels were associated with higher CVD risk: relative to estimated preindustrial levels of 0.027 μg/g, bone lead levels of 5 μg/g, 10 μg/g, 25 μg/g, 50 μg/g, and 100 μg/g corresponded to 7.5% (95% uncertainty interval [UI], 1.7%-14.1%), 15.8% (95% UI, 12.7%-19.1%), 41.3% (95% UI, 34.2%-49.2%), 71.3% (95% UI, 55.4%-90.0%), and 87.9% (95% UI, 61.0%-121.2%) greater CVD mortality risk, respectively. Globally in 2023, 3.5 million (95% UI, 2.6 million to 4.4 million) deaths and 71.6 million (95% UI, 52.4 million to 90.3 million) DALYs were attributable to lead exposure, accounting for 5.8% (95% UI, 4.3%-7.2%) of all deaths and 2.6% (95% UI, 1.8%-3.2%) of all DALYs. Lead was the eighth leading risk for global mortality and second leading environmental risk. CONCLUSIONS AND RELEVANCE: Cumulative lead exposure remains a major, preventable contributor to global CVD mortality. Strengthened surveillance, regulation, and remediation are urgently required to reduce the lead-attributable burden.
引用
- Stanaway JD, Spearman S, DeCleene NK, et al. Lead-Attributable Cardiovascular Disease Burden: Global Burden of Disease Study 2023. JAMA. 2026. PMID: 41910985. doi:10.1001/jama.2026.2197
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。